Bell Chris D, Howard Rick D, Taylor D Scott, Voss Ed D, Werpy Natasha M
Arizona Equine Medical and Surgical Center, 1685 S Gilbert Rd, Gilbert, AZ 85296, USA.
J Am Vet Med Assoc. 2009 Apr 1;234(7):920-5. doi: 10.2460/javma.234.7.920.
To determine clinical outcome following intrathecal injection of the podotrochlear (navicular) bursa for signs of foot pain in horses evaluated via magnetic resonance imaging (MRI) and evaluate efficacy of corticosteroids administered with or without hyaluronate.
Retrospective case series.
23 horses.
Data collected included signalment, history, intended use, duration and severity of lameness, results of diagnostic anesthesia, radiographic abnormalities, MRI abnormalities, and outcomes for return to use.
MRI was conducted on 23 horses with lameness localized to the foot. Thirteen horses had bilateral forelimb lameness, and 10 had unilateral forelimb lameness. Mean duration of lameness was 10.5 months. Seventeen of 23 (74%) horses had excellent outcomes and returned to intended use within 2 to 4 weeks after navicular bursa injection. Hyaluronate treatment was not associated with outcome; however, horses receiving < 10 mg of trimacinolone had significantly worse outcomes than those treated with hyaluronate. Among horses with excellent outcomes, mean duration of soundness was 7.3 months. Seven of 8 horses with erosive lesions of the flexor surface of the distal sesamoid (navicular) bone diagnosed via MRI had a poor outcome. Horses with navicular bursitis responded optimally to injection, compared with horses with other problems.
Results suggested that intrathecal injection of corticosteroid in horses with erosions of the flexor surface of the navicular bone associated with deep digital flexor tendon adhesions yielded a poor response. Treatment of horses with navicular bursitis via injection of the navicular bursa should be highly effective in alleviating lameness.
通过磁共振成像(MRI)评估,确定鞘内注射舟状滑囊治疗马足部疼痛体征后的临床结局,并评估联合或不联合透明质酸使用皮质类固醇的疗效。
回顾性病例系列研究。
23匹马。
收集的数据包括特征、病史、预期用途、跛行的持续时间和严重程度、诊断性麻醉结果、放射学异常、MRI异常以及恢复使用的结局。
对23匹足部跛行的马进行了MRI检查。13匹马为双侧前肢跛行,10匹马为单侧前肢跛行。跛行的平均持续时间为10.5个月。23匹马中有17匹(74%)预后良好,在舟状滑囊注射后2至4周内恢复到预期用途。透明质酸治疗与预后无关;然而,接受曲安奈德<10mg的马的预后明显比接受透明质酸治疗的马差。在预后良好的马中,平均健康持续时间为7.3个月。通过MRI诊断为远籽骨(舟状骨)屈面糜烂性病变的8匹马中有7匹预后不良。与有其他问题的马相比,舟状滑囊炎的马对注射反应最佳。
结果表明,对伴有指深屈肌腱粘连的舟状骨屈面糜烂的马进行鞘内注射皮质类固醇反应不佳。通过注射舟状滑囊治疗马的舟状滑囊炎在减轻跛行方面应非常有效。